Saturday 17 October 2026
Export TEM’s income statement to Excel — free account
Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024. In the quarter to June 2026, revenue grew 21.6%, EPS grew 112.0%, free cash flow fell 153.7% and total debt rose 70.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three.
64.72
6.41
−9.01%
Follow TEM
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
Piotroski F-Score |
— | — | 5 | 4 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | (1.69) | 2.60 |
P/S ratio |
4.54 | 4.54 | 5.84 | 8.09 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(6.63) | (9.79) | (9.85) | (1.60) |
P/Operating CF |
(25.18) | (25.18) | (103.08) | (279.72) |
Beneish M-Score |
— | (2.35) | (4.73) | (1.25) |
P/B ratio |
0.00 | 0.00 | 71.82 | 20.94 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
5.17 | 5.17 | 5.82 | 8.47 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(11.64) | (11.64) | (21.33) | (49.41) |
EV/FCF |
(10.23) | (10.23) | (19.10) | (43.92) |
Quick Ratio |
2.25 | 1.26 | 2.07 | 2.86 |
Current Ratio |
2.52 | 1.51 | 2.29 | 3.13 |
Net Debt/EBITDA |
(0.38) | (1.62) | 0.02 | (3.32) |
Debt/Assets |
61.70% | 79.72% | 47.02% | 54.49% |
Debt/Equity |
(0.34) | (0.33) | 7.73 | 2.52 |
Asset Turnover |
0.00 | 0.89 | 0.93 | 0.79 |
Operating CF/Net income |
0.50 | 0.81 | 0.25 | 0.89 |
Capex/Depreciation |
(0.52) | (0.86) | (0.50) | (0.26) |
Interest Coverage |
(12.12) | (4.18) | (12.88) | (3.60) |
| 0.00% | 21.18% | 112.58% | (89.48%) | |
| 0.00% | (44.50%) | (100.17%) | (15.31%) | |
ROIC |
0.00% | 0.00% | (992.66%) | (16.20%) |
Return on Tangible Assets |
(108.24%) | (148.26%) | (171.73%) | (27.72%) |
Average Days of Receivables |
100.94 | 64.83 | 81.50 | 89.30 |
Research and Development Expense of Revenue |
50.60% | 34.88% | 45.69% | 25.09% |
Selling, General and Administrative Expense of Revenue |
72.78% | 55.80% | 108.93% | 57.54% |
Intangible Assets out of Total Assets |
0.14 | 0.17 | 0.09 | 0.36 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 77.03% | 9.81% |
Graham Net Nets |
(0.66) | (0.66) | (0.05) | (0.06) |
Graham Number |
0.00 | 40.76 | 0.00 | 0.00 |
Earnings Yield |
(8.80%) | (8.80%) | (24.94%) | (2.39%) |
Free Cash Flow Yield |
(11.12%) | (11.12%) | (5.22%) | (2.38%) |
Revenue per Share |
5.09 | 8.40 | 5.79 | 7.30 |
Operating CF per Share |
(2.67) | (3.39) | (1.58) | (1.25) |
Capex per Share |
(0.29) | (0.55) | (0.18) | (0.16) |
Free Cash Flow per Share |
(2.96) | (3.93) | (1.76) | (1.41) |
Cash per Share |
4.81 | 3.12 | 3.74 | 4.33 |
Shareholders Equity per Share |
(17.91) | (21.83) | 0.47 | 2.82 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(17.91) | (21.83) | 0.47 | 2.82 |
Free Cash Flow |
(186.58) | (248.95) | (211.17) | (245.35) |
Working Capital |
264.39 | 117.70 | 376.53 | 794.79 |
Capital Expenditures |
(18.38) | (34.61) | (22.12) | (27.26) |
Net Current Asset Value |
(1,321.76) | (1,595.88) | (202.17) | (616.34) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.06 | 0.07 | 0.03 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||
Depreciation/Fixed assets |
0.81 | 0.65 | 0.76 | 1.20 |
Cash ROIC |
42.74% | 33.87% | (22.46%) | (9.87%) |
Accounts Receivable Turnover |
0.00 | 5.81 | 5.56 | 5.46 |
Accounts Payable Turnover |
0.00 | 4.89 | 5.77 | 6.98 |
Inventory Turnover |
0.00 | 9.61 | 9.29 | 10.52 |
Average Days of Payables |
88.12 | 80.86 | 62.89 | 63.15 |
Days of Inventory on Hand |
42.70 | 42.86 | 44.87 | 39.84 |
Average Receivables |
— | 91.57 | 124.64 | 232.99 |
Average Payables |
— | 50.20 | 54.11 | 67.90 |
Average Inventory |
— | 25.56 | 33.62 | 45.06 |
Average Assets |
— | 597.71 | 745.08 | 1,600.48 |
Average Common Equity |
— | (1,255.59) | (662.91) | 273.83 |
Columns are period end dates